NJ State Employees Deferred Compensation Plan’s Ionis Pharmaceuticals IONS Stock Holding History

NJ State Employees Deferred Compensation Plan’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-42,000	Closed	-$2.75M	–	199
2025 Q3	$2.75M	Hold	42,000	–	–	0.3%	80
2025 Q2	$1.66M	Hold	42,000	–	–	0.2%	116
2025 Q1	$1.27M	Hold	42,000	–	–	0.16%	146
2024 Q4	$1.47M	Hold	42,000	–	–	0.18%	126
2024 Q3	$1.68M	Hold	42,000	–	–	0.2%	115
2024 Q2	$2M	Hold	42,000	–	–	0.25%	88
2024 Q1	$1.82M	Hold	42,000	–	–	0.23%	96
2023 Q4	$2.12M	Hold	42,000	–	–	0.29%	87
2023 Q3	$1.91M	Hold	42,000	–	–	0.29%	85
2023 Q2	$1.72M	Hold	42,000	–	–	0.25%	96
2023 Q1	$1.5M	Hold	42,000	–	–	0.23%	104
2022 Q4	$1.59M	Hold	42,000	–	–	0.26%	98
2022 Q3	$1.86M	Hold	42,000	–	–	0.32%	80
2022 Q2	$1.55M	Hold	42,000	–	–	0.25%	102
2022 Q1	$1.55M	Hold	42,000	–	–	0.21%	114
2021 Q4	$1.28M	Hold	42,000	–	–	0.16%	140
2021 Q3	$1.41M	Hold	42,000	–	–	0.19%	121
2021 Q2	$1.68M	Hold	42,000	–	–	0.22%	106
2021 Q1	$1.89M	Buy	42,000 +30,000	+250%	+$1.67M	0.27%	92
2020 Q4	$678K	Hold	12,000	–	–	0.1%	199
2020 Q3	$569K	Hold	12,000	–	–	0.1%	192
2020 Q2	$708K	Hold	12,000	–	–	0.13%	163
2020 Q1	$567K	Hold	12,000	–	–	0.13%	146
2019 Q4	$725K	Hold	12,000	–	–	0.12%	170
2019 Q3	$719K	Hold	12,000	–	–	0.13%	153
2019 Q2	$771K	Hold	12,000	–	–	0.14%	144
2019 Q1	$974K	Sell	12,000 -18,000	-60%	-$1.16M	0.18%	120
2018 Q4	$1.62M	Hold	30,000	–	–	0.34%	76
2018 Q3	$1.55M	Sell	30,000 -3,000	-9%	-$141K	0.26%	87
2018 Q2	$1.38M	Sell	33,000 -1,000	-3%	-$44.3K	0.25%	95
2018 Q1	$1.5M	Sell	34,000 -3,000	-8%	-$152K	0.27%	91
2017 Q4	$1.86M	Sell	37,000 -8,000	-18%	-$439K	0.32%	75
2017 Q3	$2.28M	Sell	45,000 -5,000	-10%	-$262K	0.41%	55
2017 Q2	$2.54M	Sell	50,000 -20,000	-29%	-$931K	0.48%	47
2017 Q1	$2.81M	Hold	70,000	–	–	0.53%	36
2016 Q4	$3.35M	Hold	70,000	–	–	0.67%	26
2016 Q3	$2.56M	Hold	70,000	–	–	0.53%	40
2016 Q2	$1.63M	Hold	70,000	–	–	0.35%	83
2016 Q1	$3.26M	Hold	70,000	–	–	0.69%	23
2015 Q4	$4.33M	Hold	70,000	–	–	0.89%	15
2015 Q3	$2.83M	Hold	70,000	–	–	0.61%	32
2015 Q2	$4.03M	Hold	70,000	–	–	0.78%	17
2015 Q1	$4.46M	Hold	70,000	–	–	0.86%	13
2014 Q4	$4.32M	Hold	70,000	–	–	0.84%	15
2014 Q3	$2.72M	Hold	70,000	–	–	0.55%	36
2014 Q2	$2.41M	Buy	70,000 +50,000	+250%	+$1.57M	0.48%	45
2014 Q1	$864K	Hold	20,000	–	–	0.18%	208
2013 Q4	$797K	Hold	20,000	–	–	0.16%	231
2013 Q3	$751K	Hold	20,000	–	–	0.16%	230
2013 Q2	$537K	Buy	+20,000	New	+$425K	0.12%	280

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's IONS Position: Q4 2025 in Review

NJ State Employees Deferred Compensation Plan sold out of Ionis Pharmaceuticals (IONS) in Q4 2025, closing a stake of 42,000 shares — an estimated $2.75M sold.

NJ State Employees Deferred Compensation Plan first reported a position in IONS in Q2 2013 and held it in 50 quarters. The position peaked at $4.46M in Q1 2015. 491 funds tracked by Wall St. Rank hold IONS as of Q4 2025.

NJ State Employees Deferred Compensation Plan reported no remaining Ionis Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
NJ State Employees Deferred Compensation Plan sold 42,000 Ionis Pharmaceuticals shares in Q4 2025, an estimated $2.75M.
NJ State Employees Deferred Compensation Plan first reported a position in Ionis Pharmaceuticals in Q2 2013 and held it in 50 quarters.
NJ State Employees Deferred Compensation Plan's Ionis Pharmaceuticals position peaked at $4.46M in Q1 2015.
491 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2025.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q4 2025.